In vitro photodynamic effect of aluminum tetrasulfophthalocyanines on melanoma skin cancer and healthy normal skin cells

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 1, 2012, Pages 32-39

  Maduray, K ^a,b   Odhav, B ^b   Nyokong, T ^c  

^a DSI CSIR Nanotechnology Innovation Centre   (South Africa)

^b DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^c RHODES UNIVERSITY   (South Africa)

Author keywords

Aluminum tetrasulfophthalocyanines; Fibroblast cells; Keratinocyte cells; Melanoma cancer; Photodynamic therapy

Indexed keywords

TETRASULFOPHTHALOCYANINE ALUMINUM;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL NUCLEUS; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LOW LEVEL LASER THERAPY; MELANOMA; MELANOMA CELL; PHOTOSENSITIZATION; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; SKIN FIBROBLAST; TRANSMISSION ELECTRON MICROSCOPY;

CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FLUORESCENT DYES; HUMANS; INDOLES; KERATINOCYTES; MELANOMA; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 84857499990     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.07.001     Document Type: Article

References (22)

1. Garbe C., Peris K., Hauschild A., et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelines. European Journal of Cancer 2010, 46:270-283.
2. Elias E.G., Hasskamp J.H., Sharma B.K. Biology of human cutaneous melanoma. Cancers 2010, 2:165-189.
3. Lin H.S., Adaptation cross-resistance: an explanation for the existence of different radiosensitivities among malignant melanoma cells. Medical hypotheses 1995, 44:73-76.
4. Lawson D.H. Choices in adjuvant therapy of melanoma. Cancer Control 2005, 12:236-241.
5. Prasanthi S., Kranthi T., Bharani N.L.S., Radha Rani V., Syamala B., Srinivasulu K. Cancer vaccines: a mile stone in cancer therapy. International Journal of Biotechnology and Biochemistry 2010, 6:259-269.
6. Fuchs J., Thiele J. The role of oxygen in cutaneous photodynamic therapy. Free Radical Biology and Medicine 2008, 2:835-847.
7. Celli J.P., Spring P.Q., Rizvi I., et al. Imaging and photodynamic therapy: mechanisms, monitoring and optimization. Chemical Reviews 2010, 110:2795-2838.
8. Liu M.O., Tai C., Sain M., Hu A.T., Chou F. Photodynamic applications of phthalocyanines. Journal of photochemistry and Photobiology A: Chemistry 2004, 165:131-136.
9. Ogunsipe A., Durmuş M., Atilla D., Gürek A.G., Ahsen V., Nyokong T. Synthesis, photophysical and photochemical studies on long chain zinc phythalocyanines. Synthetic Metals 2008, 158:839-847.
10. Yanik H., Aydin D., Durmuş M., Ahsen V. Peripheral and non-peripheral tetrasubstituted aluminum, gallium and indium phthalocyanines: synthesis, photophysics and photochemistry. Journal of Photochemistry and Photobiology A: Chemistry 2009, 206:18-26.
11. Seotsanyana-Mokhosi I., Kresfelder T., Abrahamse H., Nyokong T. The effect of Ge, Si, and Sn phthalocyanine photosensitizers on the cell proliferation and viability of human oesophageal carcinoma cells. Journal of Photochemistry and Photobiology B: Biology 2006, 83:55-62.
12. Edrei R., Kimel S. Oxygen depletion during in vitro photodynamic therapy: structure-activity relationships of sulfonated aluminum phthalocyanines. Journal of Photochemistry and Photobiology B: Biology 1999, 50:197-203.
13. Masilela N., Nyokong T. The synthesis and photophysical properties of novel cationic tetra pyridiloxy substituted aluminum, silicon and titanium phthalocyanines in water. Journal of Luminescence 2010, 130:1787-1793.
14. Davids L.M., Kleemann B., Kacerovská D., Pizinger K., Kidson S.H. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. Journal of Photochemistry and Photobiology B: Biology 2008, 91:67-76.
15. Weber J., Busch D.H. Inorganic Chemistry 1965, 4:469.
16. Klotz L.O., Fritsch C., Briviba K., Tsacmacidis N., Schliess F., Sies H. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. Cancer Research 1998, 58:4297-4300.
17. Chidawanyika W., Nyokong T. The synthesis and photophysicochemical properties of low-symmetry zinc phthalocyanine analogues. Journal of Photochemistry and Photobiology A: Chemistry 2009, 206:169-176.
18. Ketabchi A., MacRobert A., Speight P.M., Bennet J.H. Induction of apoptotic cell death by photodynamic therapy in human keratinocyte. Archives of Oral Biology 1998, 43:143-149.
19. Juarranz A., Villanueva A., Diaz V., Caňete M. Photodynamic effects of the cationic porphyrin, mesotetra (4N-methylpyridyl) porphine, on microtubules of Hela cells. Journal of Photochemistry and Photobiology B: Biology 1995, 27:47-53.
20. Plaetzer K., Krammer B., Berlanda J., Berr F., Kiesslich T. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Laser Medical Science 2009, 24:259-268.
21. Macdonald I.J., Dougherty T.J. Basic principles of photodynamic therapy. Journal of Porphyrins and Phthalocyanines 2001, 5:105-129.
22. Stewart F., Baas P., Star W. What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)?. Radiotherapy and Oncology 1998, 48:233-248.